SLN logo

Silence Therapeutics plc

SLN
Healthcare|Biotechnology|GB
$19.73
+0.01 (+0.05%)
DCF Value
$1.78
Tangible Book / Share
$1.77
Cash / Share
$4.58
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Aug 12, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Sep 2026
P1P2
Study to Assess SLN124 in Patients With Polycythemia Vera
NCT05499013

Recent Press Releases

Silence Therapeutics Announces Oral Presentation on SANRECO Phase 2 Study of Divesiran in Polycythemia Vera at ASH 2026
Nov 4, 2026 · Business Wire
Silence Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silence Therapeutics plc - SLN
Oct 21, 2026 · Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
Oct 20, 2026 · GlobeNewsWire
SLN Stock Alert: Halper Sadeh LLC is Investigating Whether Silence Therapeutics plc is Obtaining a Fair Price for its Shareholders
Oct 19, 2026 · Business Wire
Merck KGaA, Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset
Oct 19, 2026 · Business Wire
Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany
Oct 19, 2026 · Business Wire
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs
Aug 14, 2026 · Business Wire
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
Aug 11, 2026 · Business Wire
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
Aug 10, 2026 · Business Wire
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
Aug 10, 2026 · Business Wire

SEC Filings (67)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 19, 2026DEFA14AProxy / shareholder voteDocumentIndex
Oct 19, 2026DEFA14AProxy / shareholder voteDocumentIndex
Oct 19, 20268-KMaterial eventDocumentIndex
Oct 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 13, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 12, 2026424B5Offering prospectusDocumentIndex
Aug 11, 2026S-3MEFShelf registrationDocumentIndex
Aug 10, 2026424B5Offering prospectusDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
Aug 10, 202610-QQuarterly reportDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
Jul 16, 20268-K/AMaterial eventDocumentIndex
Jul 8, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
Jun 16, 20268-KMaterial eventDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
May 27, 2026EFFECTDocumentIndex
May 27, 2026424B5Offering prospectusDocumentIndex
May 18, 20268-KMaterial eventDocumentIndex
May 18, 2026S-3Shelf registrationDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 5, 2026S-8Employee stock planDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 9, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 22, 20258-K/AMaterial eventDocumentIndex
Dec 22, 20258-KMaterial eventDocumentIndex
Dec 15, 20258-KMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 23, 20258-KMaterial eventDocumentIndex
Aug 14, 20258-KMaterial eventDocumentIndex
Aug 7, 202510-QQuarterly reportDocumentIndex